Most Recent Articles by Jason Harris
The PROMISE trial showed superior efficacy of triple-drug ART in preventing mother-to-child transmission of HIV.
Researchers evaluated the prevalence of late recurrent viremia following sofosbuvir-based treatment.
Diagnostic sensitivity and specificity were 100% for the quantitative real-time reverse-transcriptase assay.
Researchers did not observe a significant improvement with hydrocortisone over placebo for time until septic shock or mortality.
Tryptophan starvation did not completely block chlamydial development in high-risk human papillomavirus (HPV) negative C33A cell lines.
More Articles by Jason Harris
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Guideline Update: Influenza Immunization Recommendations for 2017-2018
- Update on Pediatric HCV: Screening, Treatment, and Other Considerations
- Time to Sputum Culture Conversion Similar in Isoniazid-Resistant and Susceptible TB
- HPV Vaccine Does Not Increase Risk for Adverse Maternal, Infant Outcomes
- DAAs Effective for HCV in Patients With Thalassemia
- Mycoplasma genitalium: Challenges in Diagnosis and Treatment
- FDA: Vabomere Approved for Complicated UTI Following Priority Review
- Update on Safe, Effective Treatments for Latent Tuberculosis Infection
- New CDC Guidelines for SSI Prevention Leave Unanswered Questions
- Influenza Vaccination During Pregnancy Reduces Infant Risk for Acute Lower Respiratory Infection